Biomarkers improve clinical outcome predictors of mortality following non-penetrating severe traumatic brain injury (Q44923505)

7 December 2017

Biomarkers improve clinical outcome predictors of mortality following non-penetrating severe traumatic brain injury (English)

1 reference

7 December 2017

0 references

traumatic brain injury

0 references

author

Kevin K W Wang

3

1 reference

7 December 2017

5

1 reference

7 December 2017

Gretchen M Brophy

4

0 references

author name string

Linda Papa

1

1 reference

7 December 2017

Claudia S Robertson

2

1 reference

7 December 2017

Shelley Heaton

6

1 reference

7 December 2017

Ilona Schmalfuss

7

1 reference

7 December 2017

Andrea Gabrielli

8

1 reference

7 December 2017

Ronald L Hayes

9

1 reference

7 December 2017

Steven A Robicsek

10

1 reference

7 December 2017

1 February 2015

1 reference

7 December 2017

1 reference

7 December 2017

22

1 reference

7 December 2017

1

1 reference

7 December 2017

52-64

1 reference

https://scigraph.springernature.com/pub.10.1007/s12028-014-0028-2

7 December 2017

0 references

cites work

The epidemiology of traumatic brain injury

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

The neurophysiology of brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Biomarkers of proteolytic damage following traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Rapid discovery of putative protein biomarkers of traumatic brain injury by SDS-PAGE-capillary liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Serum markers of brain damage and outcome prediction in patients after severe head injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Serum S-100B protein monitoring in patients with severe traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Serum S100B concentrations are increased after closed head injury in children: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

A soluble protein characteristic of the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

S-100B and neuron-specific enolase in serum of mild traumatic brain injury patients. A comparison with health controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Predictive value of S-100B protein and neuron specific-enolase as markers of traumatic brain damage in clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Proteomic identification of biomarkers of traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Serum biomarker concentrations and outcome after pediatric traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Neurocognitive outcome and serum biomarkers in inflicted versus non-inflicted traumatic brain injury in young children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

alphaII-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

αII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Serum concentrations of ubiquitin C-terminal hydrolase-L1 and αII-spectrin breakdown product 145 kDa correlate with outcome after pediatric TBI

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

A panel of neuron-enriched proteins as markers for traumatic brain injury in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Predicting outcome after traumatic brain injury: development and international validation of prognostic scores based on admission characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Protein biomarkers for traumatic and ischemic brain injury: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Use of biomarkers for diagnosis and management of traumatic brain injury patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Predicting outcome after traumatic brain injury: practical prognostic models based on large cohort of international patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Brain spectrin: of mice and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Brain spectrin(240/235) and brain spectrin(240/235E): two distinct spectrin subtypes with different locations within mammalian neural cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Biochemical, structural, and biomarker evidence for calpain-mediated cytoskeletal change after diffuse brain injury uncomplicated by contusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Role of serum S100B as a predictive marker of fatal outcome following isolated severe head injury or multitrauma in males.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Compression alters kinase and phosphatase activity and tau and MAP2 phosphorylation transiently while inducing the fast adaptive dendritic remodeling of underlying cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Rapid dephosphorylation of microtubule-associated protein 2 in the rat brain hippocampus after pentylenetetrazole-induced seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Diminished microtubule-associated protein 2 (MAP2) immunoreactivity following cortical impact brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Novel differential neuroproteomics analysis of traumatic brain injury in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Large between-center differences in outcome after moderate and severe traumatic brain injury in the international mission on prognosis and clinical trial design in traumatic brain injury (IMPACT) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Increased levels of serum MAP-2 at 6-months correlate with improved outcome in survivors of severe traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Selective release of calpain produced alphalI-spectrin (alpha-fodrin) breakdown products by acute neuronal cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Simultaneous Degradation of αII- and βII-Spectrin by Caspase 3 (CPP32) in Apoptotic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Processing of cdk5 Activator p35 to Its Truncated Form (p25) by Calpain in Acutely Injured Neuronal Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0028-2

Low sensitivity of the anion gap as a screen to detect hyperlactatemia in critically ill patients.

21 January 2018

1 reference

12 December 2020

Renal elimination of protein S-100beta in pigs with acute encephalopathy

1 reference

12 December 2020

Comparison of serial S-100 and NSE serum measurements after severe head injury

1 reference

12 December 2020

The demonstration of new human brain-specific proteins by high-resolution two-dimensional polyacrylamide gel electrophoresis

1 reference

12 December 2020

Diagnostic significance of serum neuron-specific enolase and myelin basic protein assay in patients with acute head injury

1 reference

12 December 2020

Neuron-specific enolase.

1 reference

12 December 2020

[Pathophysiological alterations in cultured astrocytes exposed to hypoxia/reoxygenation]

1 reference

12 December 2020

S-100ao protein in blood and urine during open-heart surgery.

1 reference

12 December 2020

Elimination of S100B and renal function after cardiac surgery

1 reference

12 December 2020

Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children

1 reference

12 December 2020

Comparison of percutaneous ventriculostomies and intraparenchymal monitor: a retrospective evaluation of 156 patients.

1 reference

12 December 2020

End-tidal carbon dioxide is associated with mortality and lactate in patients with suspected sepsis

1 reference

12 December 2020

Traumatic brain damage: serum S-100 protein measurements related to neuroradiological findings

1 reference

12 December 2020

Differential distribution of immunoreactive S100-alpha and S100-beta proteins in normal nonnervous human tissues

1 reference

12 December 2020

10.1007/S12028-014-0028-2

Identifiers

DOI

1 reference

7 December 2017

1 reference